This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of systemic therapies on the prevention or management of AIMSS in patients with Stage I-III hormone receptor-positive breast cancer.
CITATION STYLE
Roberts, K. E., Rickett, K., Chatfield, M. D., & Woodward, N. E. (2018, November 5). Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD013167
Mendeley helps you to discover research relevant for your work.